RETRACTIONS AND CORRECTIONS IN CURCUMIN AND TURMERIC RESEARCH: A BIBLIOMETRIC AND RESEARCH-INTEGRITY ANALYSIS
Open Access
- 30 September 2026
- journal article
- Published by South Kazakhstan Medical Academy in Central Asian Journal of Medical Hypotheses and Ethics
- Vol. 7 (3) , 346-353
Abstract
Background. Curcumin, the main curcuminoid found in turmeric, is one of the most promising candidates for the treatment of inflammatory and rheumatic diseases. This study analysed retracted and corrected publications on the anti-inflammatory and anti-rheumatic properties of turmeric.Methods. We used data exports from the Retraction Watch database to analyse retracted and corrected publications in curcumin and turmeric research. We conducted a cross-sectional analysis and identified all relevant publications on curcumin and turmeric by title, with no restrictions on publication dates. The analysis included fields such as title, Digital Object Identifier (DOI), number of authors, publication and retraction dates, journal title, publisher, country, article type, subject area, nature of the notification, and reasons for retraction. We reported time between publication and retraction.Results. A total of 123 retraction-related records corresponding to 113 unique publications; by notice type, 105 were retracted, 11 corrected, and 7 expressions of concern. The highest number of retractions was recorded in 2023 (n=21) and 2022 (n=15). The median number of authors was 6 (range 2–20). The average time from the date of publication to retraction was 963 days. The leading countries by corresponding authors were China (n=63), the United States (n=28), and India (n=21). The main reasons for retraction were data-related issues (n=74), duplication (n=57), and authorship issues/disputes (n=28). Sixteen reports mentioned involvement of paper mills. Twelve reports referred to inflammatory diseases or arthritis.Conclusion. Retractions in curcumin and turmeric research have increased due to data integrity and duplication issues, with retractions peaking in 2022 and 2023. Some retracted publications are cited in systematic reviews on curcumin use for arthritis and inflammatory diseases.Keywords
This publication has 31 references indexed in Scilit:
- Scientific retractions: causes, processes, and implications for research integrityNaunyn-Schmiedeberg's Archives of Pharmacology, 2026
- Should we be worried? Retractions in complementary and alternative medicine journalsEXPLORE, 2025
- Effects of curcumin and Curcuma longa extract on inflammatory biomarkers in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE): a systematic review and meta-analysis of randomized controlled trialsInflammation Research, 2025
- Inclusion of Retracted Studies in Systematic Reviews and Meta-Analyses of InterventionsJAMA Internal Medicine, 2025
- A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailabilityiScience, 2025
- Retracted articles in scientific literature: A bibliometric analysis from 2003 to 2022 using the Web of ScienceHeliyon, 2024
- Retracted papers originating from paper mills: a cross-sectional analysis of references and citationsJournal of Clinical Epidemiology, 2024
- Retracted articles in the biomedical literature from Indian authorsScientometrics, 2021
- Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled TrialsCurrent Rheumatology Reports, 2021
- Post retraction citations in context: a case studyScientometrics, 2017